Tvardi Therapeutics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Tvardi Therapeutics, Inc. (TVRD) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022
Period EndingDec 2024Dec 2023Dec 2022
Operating Activities
Net Income-70.87-17.35-20.54
Depreciation & Amortization0.190.100.09
Stock Based Compensation0.000.310.25
Change in Working Capital-15.10-3.962.67
Change in Accounts Receivable2.020.000.00
Change in Inventory-1.040.000.00
Change in Accounts Payable-21.44-1.012.20
Change in Other Working Capital5.36-2.950.03
Other Operating Activities24.860.050.03
Net Cash from Operating Activities-60.92-21.04-17.87
Investing Activities
Capital Expenditures-1.050.00-0.05
Purchases of Investments-32.2122.47-44.00
Sales/Maturities of Investments82.0022.4722.05
Net Cash from Investing Activities48.7422.47-22.00
Financing Activities
Debt Repayment-3.600.000.00
Common Stock Issued0.000.000.00
Net Cash from Financing Activities-3.600.000.00
Summary
Effect of Forex Changes on Cash1.500.000.00
Net Change in Cash-14.281.43-39.86
Cash at Beginning of Period52.1821.4961.35
Cash at End of Period37.9022.9221.49
Free Cash Flow-61.96-21.04-17.92